To further explore the impact of SPNS2 on CRC progression, we then analyzed the correlation between SPNS2 expression and the clinic pathological parameters of CRC patients in TCGA CRC datasets, including COAD (Colon adenocarcinoma) and READ (Rectum adenocarcinoma). The gene discussed is SPNS2; the disease is colorectal carcinoma.